LE WE PMID CA
Diabetes mellitus T1DM (Type1)677Diabetes mellitus (Typ1)

Adrenal gland (Insufficiency)

Amylin

Anemia (Pernicious)

Autoantibodies Anti 21 Hydroxylase

Autoantibodies Anti CCP

Autoantibodies Anti Glutamate decarboxylase GAD65

Autoantibodies Anti Insulin

Autoantibodies Anti Intrinsic factor

Autoantibodies Anti Islet antigen 2 IA2

Autoantibodies Anti Parietal cell

Autoantibodies Anti PDX1

Autoantibodies Anti Zinc transporter 8

Autoimmune gastritis

Autoimmune polyglandular syndrome

Autoimmunity

C Peptide

CXCL10

CXCR3

Diabetes mellitus (Dyslipidemia)

Diabetes mellitus (Involvement central peripheral autonomic nervous systems)

Diabetes mellitus (LADA)

Diabetes mellitus T1DM (Type1)

Diabetes mellitus T2DM (Type2)

Gastrin

Glucose (Hypoglycemia)

Glutamic acid decarboxylase

Granzyme

HMGB1

NK cells

NOD mouse

Perforin

Stomach (Neoplasia)

T cell (CTL)

Teplizumab ttCD3

2005  
1
Immunology of type 1 diabetes.
[15955793] QJM 98(8): 547-56 (2005)
2007  
2
Prevalence and clinical significance of organ-specific autoantibodies in type 1 diabetes mellitus.
[17656810] Neth J Med 65(7): 235-47 (2007)
2007  
3
Autoantibodies against multiple tissues in type 1 diabetes.
[17656808] Neth J Med 65(7): 225-6 (2007)
2004  
4
Autoantibody testing in children with newly diagnosed type 1 diabetes mellitus.
[15191683] Health Technol Assess 8(22): iii-xi, 1-183 (2004)
2009  
5
Post-mortem analysis of islet pathology in type 1 diabetes illuminates the life and death of the beta cell.
[19128357] Clin Exp Immunol 155(2): 125-7 (2009)
2009  
6
Glutamic Acid decarboxylase therapy for recent-onset type 1 diabetes: are we at the end or the beginning of finding a cure?
[20144352] J Diabetes Sci Technol 3(2): 215-8 (2009)
2002  
7
Treatment of patients who have type 1 diabetes mellitus: physiological misconceptions and infusion pump therapy.
[12198989] J Am Dent Assoc 133(8): 1088-92; quiz 1095 (2002)
1998  
8
Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop.
[9836516] Diabetes 47(12): 1857-66 (1998)
2006  
9
Clinical review: Type 1 diabetes-associated autoimmunity: natural history, genetic associations, and screening.
[16403820] J Clin Endocrinol Metab 91(4): 1210-7 (2006)
2006  
10
Type 1 diabetes: pathogenesis and prevention.
[16847277] CMAJ 175(2): 165-70 (2006)
1991  
11
Insulin-dependent (type I) diabetes mellitus.
[1933705] CMAJ 145(10): 1227-37 (1991)
2011  
12
What causes type 1 diabetes? Lessons from animal models.
[21615797] APMIS Suppl 119 132(-): 1-19 (2011)
2009  
13
Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis.
[19248096] Arthritis Rheum 60(3): 653-60 (2009)
2010  
14
The role of perforin and granzymes in diabetes.
[19927156] Cell Death Differ 17(4): 577-85 (2010)
2010  
15
Clinical applications of diabetes antibody testing.
[19875480] J Clin Endocrinol Metab 95(1): 25-33 (2010)
2008  
16
Autoimmune gastritis in type 1 diabetes: a clinically oriented review.
[18029461] J Clin Endocrinol Metab 93(2): 363-71 (2008)
2010  
17
2010  
18
Use of nonobese diabetic mice to understand human type 1 diabetes.
[20723819] Endocrinol Metab Clin North Am 39(3): 541-61 (2010)
2010  
19
Efforts to prevent and halt autoimmune beta cell destruction.
[20723818] Endocrinol Metab Clin North Am 39(3): 527-39 (2010)
2010  
20
2009  
21
2007  
22
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus.
[17613449] Endocr Pract 13 Suppl 1(-): 1-68 (2007)
2010  
23
Enteroviral pathogenesis of type 1 diabetes.
[20807476] Discov Med 10(51): 151-60 (2010)
2011  
24
Autoantigen based vaccines for type 1 diabetes.
[21524383] Discov Med 11(59): 293-301 (2011)
2011  
25
Innate immunity in type 1 diabetes.
[21712017] Discov Med 11(61): 513-20 (2011)
2002  
26
Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes.
[11927613] J Clin Invest 109(7): 869-70 (2002)
2008  
27
Update on worldwide efforts to prevent type 1 diabetes.
[19120293] Ann N Y Acad Sci 1150(-): 190-6 (2008)
2010  
28
Type 1 diabetes in children - emergency management.
[20485715] Aust Fam Physician 39(5): 290-3 (2010)
2009  
29
Type 1 diabetes and autoimmune polyglandular syndrome: a clinical review.
[20009114] Neth J Med 67(11): 376-87 (2009)
2008  
30
Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity?
[18082388] Curr Opin Immunol 20(1): 105-10 (2008)
2010  
31
The immunotherapeutic potential of dendritic cells in type 1 diabetes.
[20491789] Clin Exp Immunol 161(2): 197-207 (2010)
2004  
32
On the mechanisms of the protective effect of infections on type 1 diabetes.
[15559363] Clin Dev Immunol 11(3-4): 191-4 (2004)
2006  
33
2005  
34
Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups.
[15793184] Diabetes Care 28(4): 850-5 (2005)
2009  
35
Beta-cell protection and therapy for latent autoimmune diabetes in adults.
[19875559] Diabetes Care 32 Suppl 2(-): S246-52 (2009)
2007  
36
New developments in the treatment of type 1 diabetes in children.
[17954479] Arch Dis Child 92(11): 1015-9 (2007)
2009  
37
Psychosocial problems in adolescents with type 1 diabetes mellitus.
[19700362] Diabetes Metab 35(5): 339-50 (2009)
2009  
38
Lipid disorders in type 1 diabetes.
[19733492] Diabetes Metab 35(5): 353-60 (2009)
2009  
39
HMGB1, an innate alarmin, in the pathogenesis of type 1 diabetes.
[19918326] Int J Clin Exp Pathol 3(1): 24-38 (2009)
2008  
40
Diabetes education for children with type 1 diabetes mellitus and their families.
[18620470] Evid Rep Technol Assess (Full Rep) -(166): 1-144 (2008)
2009  
41
The role of immunomodulation therapy in autoimmune diabetes.
[20144363] J Diabetes Sci Technol 3(2): 320-30 (2009)
2010  
42
The role of innate immune pathways in type 1 diabetes pathogenesis.
[20125005] Curr Opin Endocrinol Diabetes Obes 17(2): 126-30 (2010)
2009  
43
Change you can B(cell)eive in: recent progress confirms a critical role for B cells in type 1 diabetes.
[19502979] Curr Opin Endocrinol Diabetes Obes 16(4): 293-8 (2009)
2005  
44
Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials.
[17491686] Rev Diabet Stud 2(3): 116-20 (2005)
2009  
45
The role of the CXCL10/CXCR3 system in type 1 diabetes.
[19806237] Rev Diabet Stud 6(2): 81-4 (2009)
2009  
46
Histopathology of type 1 diabetes: old paradigms and new insights.
[19806238] Rev Diabet Stud 6(2): 85-96 (2009)
2009  
47
Sequential abnormalities in type 1 diabetic encephalopathy and the effects of C-Peptide.
[20039010] Rev Diabet Stud 6(3): 211-22 (2009)
2011  
48
Insulitis in human type 1 diabetes: The quest for an elusive lesion.
[21606672] Islets 3(4): 131-8 (2011)
2011  
49
Amylin analogues in the treatment of diabetes mellitus: medicinal chemistry and structural basis of its function.
[21966328] Open Med Chem J 5(Suppl 2): 78-81 (2011)
2011  
50
Noninsulin pharmacological management of type 1 diabetes mellitus.
[21847455] Indian J Endocrinol Metab 15(Suppl 1): S5-S11 (2011)
2009  
51
C-peptide in the natural history of type 1 diabetes.
[19267337] Diabetes Metab Res Rev 25(4): 325-8 (2009)
2011  
52
The pancreas in human type 1 diabetes.
[20495921] Semin Immunopathol 33(1): 29-43 (2011)
2010  
53
An update on the use of NOD mice to study autoimmune (Type 1) diabetes.
[20979558] Expert Rev Clin Immunol 6(6): 939-55 (2010)
2010  
54
Combination therapies for type 1 diabetes: why not now?
[20635894] Immunotherapy 2(3): 289-91 (2010)
2009  
55
APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetes.
[19036642] Clin Immunol 130(3): 272-9 (2009)
2010  
56
Teplizumab therapy for type 1 diabetes.
[20095914] Expert Opin Biol Ther 10(3): 459-65 (2010)
2010  
57
Attacking the source: anti-PDX-1 responses in type 1 diabetes.
[20038945] Lab Invest 90(1): 6-8 (2010)
2010  
58
Prediction and pathogenesis in type 1 diabetes.
[20412757] Immunity 32(4): 468-78 (2010)
2010  
59
Autoimmune polyendocrine syndromes: clues to type 1 diabetes pathogenesis.
[20412758] Immunity 32(4): 479-87 (2010)
2010  
60
Immunotherapy of type 1 diabetes: where are we and where should we be going?
[20412759] Immunity 32(4): 488-99 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.


  • Therapie des Diabetes mellitus Typ 1


  • Search PubMed and many other databases on the combined search terms

    GG: diabetes mellitus type 1
    GG: t1dm

  • Diabetes mellitus (Typ1)

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia